Navigation Links
Fight against Fungus - A new ray of hope

Fungal infections, for many of us, though very annoying, are just a harmless fact of life. But this harmless fact turns fatal for many sick people who have weakened immune systems and cannot put up a strong defense against// attacks launched against their blood vessels and internal organs.

Doctors maintain that fungal infections though not harmful killers, can create complications in many modern medical therapies rendering them ineffective for treatment of several serious diseases. Various naturally occurring fungi in our body, occasionally cause infections in places like toenails, the mouth & the vagina. Fungi can however travel into the body in patients with weakened immune systems and cause a disease called candidiasis.

Patients who are most vulnerable to candidiasis are those who are HIV-positive, those who have received organ transplants or chemotherapy and those who have catheters inserted. Doctors say that the disease can kill 30 to 40 per cent of those infected.

Until now, the "hidden plague" of fungal infections in hospitals has been combated by two main drugs - Amphotericin B and fluconazole. While the former drug, which has been around for nearly 45years works well but with serious side effects, the latter is safer, but does not work against all strains of bacteria. A new study has however discovered a new drug that works as well as the earlier ones but without the burden of bad side effects.

Dr. John Perfect, an associate professor of medicine at Duke University and his colleagues carried out a study to test the effectiveness of the new drug called caspofungin, which is manufactured by the pharma major Merck. The study, which was funded by Merck involved testing both the new drug and old ones in nearly 250 patients from around the world.

The study concluded that the new drug, caspofungin was as effective as Amphotericin B without as many side effects. However one of the main disadvantages of the dru g, besides being new and therefore costly, is that it needs to be injected intravenously. This aspect makes it difficult to use the drug outside a hospital set-up.

The drug, which has not yet been approved for use in candidiasis patients, due to its high cost will be reserved for the sickest kinds of patients who are in the hospital and for one reason or another have not responded to fluconazole.


Related medicine news :

1. Fight Heart disease and Pain with Meditation
2. Fight anemia by fortifying crops with iron!!!!!!!!
3. Fight arthritic pain with acupuncture
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Fight against E.coli
6. Red Wine Helps Fight Heart disease
7. Fish Oil Fights Arrhythmias, Sudden Death
8. SARS-Free Taiwan to Mark End Phase of Global Fight
9. Few Parents Help Kids Fight Acne
10. Common Cold Found to Fight Cancer
11. The Possibility Of Fighting HIV with Another Virus Questioned
Post Your Comments:

(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: